Europe Persistent Corneal Epithelial Defects Treatment Market - Industry Trends and Forecast to 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

4.1 DRIVERS

4.1.1 INCREASING PREVALENCE OF PERSISTENT CORNEAL EPITHELIAL DEFECTS AND OTHER RELATED COMPLICATIONS

4.1.2 RISING CASES OF EYE SURGERIES AND USAGE OF CONTACT LENSES

4.1.3 GROWING AGEING POPULATION AUGMENTING TOWARDS THE PCED CONDITION

4.1.4 INCREASE IN MECHANICAL TRAUMAS CASES

4.2 RESTRAINT

4.2.1 STRINGENT REGULATORY PROCEDURES

4.2.2 UNMET MEDICAL NEEDS FOR THE TREATMENT OF PCED

4.2.3 HIGH COST OF PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENTS

4.3 OPPORTUNITIES

4.3.1 DEVELOPMENT OF NOVEL THERAPEUTICS

4.3.2 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE

4.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

4.3.4 EMERGING MARKET ECONOMY CREATES SIGNIFICANT OPPORTUNITIES

4.4 CHALLENGES

4.4.1 DEPENDENCY ON THIRD PARTY SUPPLIERS

5 PREMIUM INSIGHTS

6 EPIDEMIOLOGY

7 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES

7.1 OVERVIEW

7.2 INFLAMMATORY DISEASE

7.3 NEUROTROPHIC KERATITIS (NK)

7.4 EPITHELIAL/LIMBAL STEM CELL DEFICIENCY

7.5 OTHERS

8 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE

8.1 OVERVIEW

8.2 DEVICES

8.2.1 BANDAGE CONTACT LENS

8.2.2 AMNIOTIC MEMBRANE GRAFTS

8.2.3 PUNCTAL PLUGS

8.2.3.1 SILICONE PLUG

8.2.3.2 COLLAGEN PLUGS

8.2.4 CORNEAL TRANSPLANTS

8.2.4.1 KERATOPLASTY

8.2.4.2 KERATOPROSTHESIS

8.3 MEDICATION

8.3.1 DRUG TYPE

8.3.1.1 LUBRICANTS

8.3.1.2 PROPHYLACTIC TOPICAL ANTIBIOTICS

8.3.1.2.1 POLYMIXIN B–TRIMETHOPRIM + FLUOROQUINOLONE

8.3.1.2.2 FLUOROQUINOLONE

8.3.1.3 TOPICAL OPHTHALMIC STEROIDS

8.3.1.4 AUTOLOGOUS SERUM TEARS/AUTOLOGOUS SERUM EYE DROPS

8.3.1.5 TETRACYCLINES

8.3.1.6 HUMAN NERVE GROWTH FACTOR (OXERVATE)

8.3.1.7 WOUND HEALING AGENTS

8.3.1.8 OTHERS

8.3.2 ROUTE OF ADMINISTRATION

8.3.2.1 TOPICAL

8.3.2.2 ORAL

9 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 HOMECARE

9.4 SPECIALTY CLINICS

9.5 OTHERS

10 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 HOSPITAL PHARMACIES

10.3 RETAIL PHARMACIES

10.4 ONLINE PHARMACIES

11 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY GEOGRAPHY

11.1 EUROPE

11.1.1 GERMANY

11.1.2 U.K.

11.1.3 FRANCE

11.1.4 ITALY

11.1.5 SPAIN

11.1.6 RUSSIA

11.1.7 NETHERLANDS

11.1.8 SWITZERLAND

11.1.9 BELGIUM

11.1.10 TURKEY

11.1.11 AUSTRIA

11.1.12 IRELAND

11.1.13 NORWAY

11.1.14 HUNGARY

11.1.15 POLAND

11.1.16 LITHUANIA

11.1.17 REST OF EUROPE

12 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 JOHNSON & JOHNSON SERVICES, INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 ALLERGAN

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENT

13.3 BIO-TISSUE (A SUBSIDIARY OF TISSUETECH, INC.)

13.3.1 COMPANY SNAPSHOT

13.3.2 COMPANY SHARE ANALYSIS

13.3.3 PRODUCT PORTFOLIO

13.3.4 RECENT DEVELOPMENTS

13.4 LABORATOIRES THÉA S.A.S

13.4.1 COMPANY SNAPSHOT

13.4.2 COMPANY SHARE ANALYSIS

13.4.3 PRODUCT PORTFOLIO

13.4.4 RECENT DEVELOPMENT

13.5 NOVARTIS AG

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 BAUSCH HEALTH

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENT

13.7 INTEGRA LIFESCIENCES CORPORATION

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENT

13.8 ALMIRALL, S.A

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENT

13.9 DOMPÉ FARMACEUTICI S.P.A.

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.10 HUNT VALLEY PHARMALAB

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.10.3 RECENT DEVELOPMENT

13.11 I-MED PHARMA INC.

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENT

13.12 KALA PHARMACEUTICALS

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 KATENA PRODUCTS. INC.

13.13.1 COMPANY SNAPSHOT

13.13.2 PRODUCT PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 NEXT BIOSCIENCES

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 RECENT DEVELOPMENT

13.15 OCULAR SCIENCE, INC.

13.15.1 COMPANY SNAPSHOT

13.15.2 PRODUCT PORTFOLIO

13.15.3 RECENT DEVELOPMENT

13.16 SKYE BIOLOGICS INC.

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 2 EUROPE INFLAMMATORY DISEASE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 EUROPE NEUROTROPHIC KERATITIS (NK) IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 EUROPE EPITHELIAL/LIMBAL STEM CELL DEFICIENCY IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 EUROPE OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 10 EUROPE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 11 EUROPE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 12 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 14 EUROPE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 15 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 16 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 17 EUROPE HOSPITALS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE HOMECARE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 EUROPE SPECIALTY CLINICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 22 EUROPE HOSPITAL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE RETAIL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 EUROPE ONLINE PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY 2018-2027 (USD MILLION)

TABLE 26 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 27 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 28 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 29 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 30 EUROPE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 31 EUROPE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 32 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 33 EUROPE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 34 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 35 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 37 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 38 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 GERMANY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 GERMANY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 41 GERMANY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 42 GERMANY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 43 GERMANY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 44 GERMANY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 45 GERMANY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 46 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 47 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 48 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 49 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 U.K. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 U.K. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 52 U.K. PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 53 U.K. CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 54 U.K. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 55 U.K. PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 56 U.K. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 57 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 58 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 59 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 60 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 FRANCE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 FRANCE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 63 FRANCE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 64 FRANCE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 65 FRANCE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 66 FRANCE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 67 FRANCE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 68 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 69 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 70 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 71 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 ITALY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 ITALY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 74 ITALY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 75 ITALY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 76 ITALY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 77 ITALY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 78 ITALY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 79 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 80 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 81 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 82 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 SPAIN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 SPAIN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 85 SPAIN PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 86 SPAIN CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 87 SPAIN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 88 SPAIN PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 89 SPAIN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 90 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 91 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 92 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 93 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 RUSSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 RUSSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 96 RUSSIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 97 RUSSIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 98 RUSSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 99 RUSSIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 100 RUSSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 101 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 102 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 103 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 104 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 105 NETHERLANDS DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 NETHERLANDS DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 107 NETHERLANDS PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 108 NETHERLANDS CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 109 NETHERLANDS MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 110 NETHERLANDS PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 111 NETHERLANDS MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 112 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 113 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 114 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 115 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 SWITZERLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 SWITZERLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 118 SWITZERLAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 119 SWITZERLAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 120 SWITZERLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 121 SWITZERLAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 122 SWITZERLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 123 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 124 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 125 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 126 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 BELGIUM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 BELGIUM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 129 BELGIUM PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 130 BELGIUM CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 131 BELGIUM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 132 BELGIUM PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 133 BELGIUM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 134 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 135 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 136 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 137 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 138 TURKEY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 TURKEY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 140 TURKEY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 141 TURKEY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 142 TURKEY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 143 TURKEY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 144 TURKEY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 145 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 146 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 147 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 148 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 AUSTRIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 AUSTRIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 151 AUSTRIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 152 AUSTRIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 153 AUSTRIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 154 AUSTRIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 155 AUSTRIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 156 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 157 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 158 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 159 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 160 IRELAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 161 IRELAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 162 IRELAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 163 IRELAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 164 IRELAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 165 IRELAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 166 IRELAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 167 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 168 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 169 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 170 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 171 NORWAY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 172 NORWAY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 173 NORWAY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 174 NORWAY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 175 NORWAY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 176 NORWAY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 177 NORWAY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 178 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 179 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 180 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 181 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 HUNGARY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 183 HUNGARY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 184 HUNGARY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 185 HUNGARY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 186 HUNGARY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 187 HUNGARY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 188 HUNGARY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 189 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 190 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 191 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 192 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 193 POLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 194 POLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 195 POLAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 196 POLAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 197 POLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 198 POLAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 199 POLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 200 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 201 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 202 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

TABLE 203 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 204 LITHUANIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 205 LITHUANIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 206 LITHUANIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 207 LITHUANIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 208 LITHUANIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 209 LITHUANIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)

TABLE 210 LITHUANIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 211 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 212 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 213 REST OF EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)